loading page

Successful implantation of a cardiac resynchronization therapy device assisted with Impella in a patient with severe decompensated heart failure
  • +7
  • Kyoko Unno,
  • Makoto Sano,
  • Yutaro Kaneko,
  • Tomoaki Sakakibara,
  • Taro Narumi,
  • Satoshi Mogi,
  • Yoshihisa Naruse,
  • Hayato Ohtani,
  • Tsuyoshi Urushida,
  • Yuichiro Maekawa
Kyoko Unno
Hamamatsu University School of Medicine
Author Profile
Makoto Sano
Hamamatsu University School of Medicine

Corresponding Author:[email protected]

Author Profile
Yutaro Kaneko
Hamamatsu University School of Medicine
Author Profile
Tomoaki Sakakibara
Hamamatsu University School of Medicine
Author Profile
Taro Narumi
Hamamatsu University School of Medicine
Author Profile
Satoshi Mogi
Hamamatsu University School of Medicine
Author Profile
Yoshihisa Naruse
Hamamatsu University School of Medicine
Author Profile
Hayato Ohtani
Hamamatsu University School of Medicine
Author Profile
Tsuyoshi Urushida
Hamamatsu University School of Medicine
Author Profile
Yuichiro Maekawa
Hamamatsu University School of Medicine
Author Profile

Abstract

Cardiac resynchronization therapy (CRT) is a cornerstone of heart failure with reduced left ventricular (LV) ejection fraction and a wide QRS duration. Implantation of a CRT device is usually scheduled in the compensated phase of heart failure. We report a case of a successful semi-urgent implantation of a CRT device assisted with Impella at the decompensated phase of severe heart failure dependent on inotropic agents. Both mechanical resynchronization by CRT and LV unloading by Impella might contribute to a decrease in LV end-diastolic pressure and early recovery from acute pulmonary edema.